speb/financial-data huggingface dataset:
BKHA cash_flow (quarterly, 2024-11-30) — Short Term Debt Payments: 0.00
BKHA balance_sheet (annual, 2024-11-30) — Stockholders Equity: 69657357.00
BKHA balance_sheet (quarterly, 2024-11-30) — Stockholders Equity: 69657357.00
BKHA balance_sheet (annual, 2024-11-30) — Tangible Book Value: 69657357.00
BKHA balance_sheet (quarterly, 2024-11-30) — Tangible Book Value: 69657357.00
BKHA income_statement (annual, 2024-11-30) — Tax Effect Of Unusual Items: 0.00
BKHA income_statement (quarterly, 2024-11-30) — Tax Effect Of Unusual Items: 0.00
BKHA income_statement (annual, 2024-11-30) — Tax Rate For Calcs: 0.21
BKHA income_statement (quarterly, 2024-11-30) — Tax Rate For Calcs: 0.21
BKHA balance_sheet (annual, 2024-11-30) — Total Assets: 72143335.00
BKHA balance_sheet (quarterly, 2024-11-30) — Total Assets: 72143335.00
BKHA balance_sheet (annual, 2024-11-30) — Total Capitalization: 69657357.00
BKHA balance_sheet (quarterly, 2024-11-30) — Total Capitalization: 69657357.00
BKHA balance_sheet (annual, 2024-11-30) — Total Equity Gross Minority Interest: 69657357.00
BKHA balance_sheet (quarterly, 2024-11-30) — Total Equity Gross Minority Interest: 69657357.00
BKHA income_statement (annual, 2024-11-30) — Total Expenses: 576076.00
BKHA income_statement (quarterly, 2024-11-30) — Total Expenses: 101268.00
BKHA balance_sheet (annual, 2024-11-30) — Total Liabilities Net Minority Interest: 2485978.00
BKHA balance_sheet (quarterly, 2024-11-30) — Total Liabilities Net Minority Interest: 2485978.00
BKHA balance_sheet (annual, 2024-11-30) — Total Non Current Assets: 71829264.00
BKHA balance_sheet (quarterly, 2024-11-30) — Total Non Current Assets: 71829264.00
BKHA balance_sheet (annual, 2024-11-30) — Total Non Current Liabilities Net Minority Interest: 2415000.00
BKHA balance_sheet (quarterly, 2024-11-30) — Total Non Current Liabilities Net Minority Interest: 2415000.00
BKHA income_statement (annual, 2024-11-30) — Total Operating Income As Reported: -576076.00
BKHA income_statement (quarterly, 2024-11-30) — Total Operating Income As Reported: -101268.00
BKHA balance_sheet (annual, 2024-11-30) — Tradeand Other Payables Non Current: 2415000.00
BKHA balance_sheet (quarterly, 2024-11-30) — Tradeand Other Payables Non Current: 2415000.00
BKHA balance_sheet (annual, 2024-11-30) — Working Capital: 243093.00
BKHA balance_sheet (quarterly, 2024-11-30) — Working Capital: 243093.00
BKHA income_statement (quarterly, 2025-02-28) — +Operating Expense: 108769.00
BKHA income_statement (quarterly, 2025-02-28) — +Total Revenue: 0.00
BKHA balance_sheet (quarterly, 2025-02-28) — Additional Paid In Capital: 0.00
BKHA income_statement (quarterly, 2025-02-28) — Basic Average Shares: 8929500.00
BKHA income_statement (quarterly, 2025-02-28) — Basic EPS: 0.07
BKHA cash_flow (quarterly, 2025-02-28) — Beginning Cash Position: 264842.00
BKHA balance_sheet (quarterly, 2025-02-28) — Capital Stock: 72595378.00
BKHA balance_sheet (quarterly, 2025-02-28) — Cash And Cash Equivalents: 101528.00
BKHA balance_sheet (quarterly, 2025-02-28) — Cash Cash Equivalents And Short Term Investments: 101528.00
BKHA balance_sheet (quarterly, 2025-02-28) — Cash Financial: 101528.00
BKHA cash_flow (quarterly, 2025-02-28) — Cash Flow From Continuing Financing Activities: 0.00
BKHA cash_flow (quarterly, 2025-02-28) — Cash Flow From Continuing Investing Activities: 0.00
BKHA cash_flow (quarterly, 2025-02-28) — Cash Flow From Continuing Operating Activities: -163314.00
BKHA cash_flow (quarterly, 2025-02-28) — Change In Accrued Expense: -1277.00
BKHA cash_flow (quarterly, 2025-02-28) — Change In Payables And Accrued Expense: -1277.00
BKHA cash_flow (quarterly, 2025-02-28) — Change In Prepaid Assets: -54505.00
BKHA cash_flow (quarterly, 2025-02-28) — Change In Working Capital: -55782.00
BKHA cash_flow (quarterly, 2025-02-28) — Changes In Cash: -163314.00
BKHA balance_sheet (quarterly, 2025-02-28) — Common Stock: 72595378.00
BKHA balance_sheet (quarterly, 2025-02-28) — Common Stock Equity: 70315736.00
BKHA balance_sheet (quarterly, 2025-02-28) — Current Accrued Expenses: 69701.00
BKHA balance_sheet (quarterly, 2025-02-28) — Current Assets: 205262.00
BKHA balance_sheet (quarterly, 2025-02-28) — Current Liabilities: 69701.00
BKHA income_statement (quarterly, 2025-02-28) — Diluted Average Shares: 8929500.00
BKHA income_statement (quarterly, 2025-02-28) — Diluted EPS: 0.07
BKHA income_statement (quarterly, 2025-02-28) — Diluted NI Availto Com Stockholders: 658379.00
BKHA income_statement (quarterly, 2025-02-28) — EBIT: 658379.00
BKHA income_statement (quarterly, 2025-02-28) — EBITDA: 658379.00
BKHA cash_flow (quarterly, 2025-02-28) — End Cash Position: 101528.00
BKHA cash_flow (quarterly, 2025-02-28) — Financing Cash Flow: 0.00
BKHA cash_flow (quarterly, 2025-02-28) — Free Cash Flow: -163314.00
BKHA income_statement (quarterly, 2025-02-28) — General And Administrative Expense: 108769.00
BKHA income_statement (quarterly, 2025-02-28) — Interest Expense: 0.00
BKHA income_statement (quarterly, 2025-02-28) — Interest Expense Non Operating: 0.00
BKHA income_statement (quarterly, 2025-02-28) — Interest Income: 767148.00
BKHA income_statement (quarterly, 2025-02-28) — Interest Income Non Operating: 767148.00
BKHA balance_sheet (quarterly, 2025-02-28) — Invested Capital: 70315736.00
BKHA cash_flow (quarterly, 2025-02-28) — Investing Cash Flow: 0.00
BKHA cash_flow (quarterly, 2025-02-28) — Issuance Of Debt: 0.00
BKHA income_statement (quarterly, 2025-02-28) — Net Income: 658379.00
BKHA income_statement (quarterly, 2025-02-28) — Net Income Common Stockholders: 658379.00
BKHA income_statement (quarterly, 2025-02-28) — Net Income Continuous Operations: 658379.00
BKHA income_statement (quarterly, 2025-02-28) — Net Income From Continuing And Discontinued Operation: 658379.00
BKHA income_statement (quarterly, 2025-02-28) — Net Income From Continuing Operation Net Minority Interest: 658379.00
BKHA cash_flow (quarterly, 2025-02-28) — Net Income From Continuing Operations: 658379.00
BKHA income_statement (quarterly, 2025-02-28) — Net Income Including Noncontrolling Interests: 658379.00
BKHA income_statement (quarterly, 2025-02-28) — Net Interest Income: 767148.00
BKHA cash_flow (quarterly, 2025-02-28) — Net Issuance Payments Of Debt: 0.00
BKHA income_statement (quarterly, 2025-02-28) — Net Non Operating Interest Income Expense: 767148.00
BKHA cash_flow (quarterly, 2025-02-28) — Net Short Term Debt Issuance: 0.00
BKHA balance_sheet (quarterly, 2025-02-28) — Net Tangible Assets: 70315736.00
BKHA income_statement (quarterly, 2025-02-28) — Normalized EBITDA: 658379.00
BKHA income_statement (quarterly, 2025-02-28) — Normalized Income: 658379.00
BKHA cash_flow (quarterly, 2025-02-28) — Operating Cash Flow: -163314.00
BKHA income_statement (quarterly, 2025-02-28) — Operating Income: -108769.00
BKHA income_statement (quarterly, 2025-02-28) — Operating Revenue: 0.00
BKHA balance_sheet (quarterly, 2025-02-28) — Ordinary Shares Number: 8929500.00
BKHA income_statement (quarterly, 2025-02-28) — Other Gand A: 108769.00
BKHA cash_flow (quarterly, 2025-02-28) — Other Non Cash Items: -765911.00
BKHA balance_sheet (quarterly, 2025-02-28) — Other Non Current Assets: 72595175.00
BKHA balance_sheet (quarterly, 2025-02-28) — Payables And Accrued Expenses: 69701.00
BKHA balance_sheet (quarterly, 2025-02-28) — Prepaid Assets: 103734.00
BKHA income_statement (quarterly, 2025-02-28) — Pretax Income: 658379.00
BKHA balance_sheet (quarterly, 2025-02-28) — Retained Earnings: -2279642.00
BKHA income_statement (quarterly, 2025-02-28) — Selling General And Administration: 108769.00
BKHA balance_sheet (quarterly, 2025-02-28) — Share Issued: 8929500.00
BKHA cash_flow (quarterly, 2025-02-28) — Short Term Debt Issuance: 0.00
BKHA balance_sheet (quarterly, 2025-02-28) — Stockholders Equity: 70315736.00
BKHA balance_sheet (quarterly, 2025-02-28) — Tangible Book Value: 70315736.00
BKHA income_statement (quarterly, 2025-02-28) — Tax Effect Of Unusual Items: 0.00
BKHA income_statement (quarterly, 2025-02-28) — Tax Rate For Calcs: 0.21
BKHA balance_sheet (quarterly, 2025-02-28) — Total Assets: 72800437.00
BKHA balance_sheet (quarterly, 2025-02-28) — Total Capitalization: 70315736.00
BKHA balance_sheet (quarterly, 2025-02-28) — Total Equity Gross Minority Interest: 70315736.00
BKHA income_statement (quarterly, 2025-02-28) — Total Expenses: 108769.00
BKHA balance_sheet (quarterly, 2025-02-28) — Total Liabilities Net Minority Interest: 2484701.00
BKHA balance_sheet (quarterly, 2025-02-28) — Total Non Current Assets: 72595175.00
BKHA balance_sheet (quarterly, 2025-02-28) — Total Non Current Liabilities Net Minority Interest: 2415000.00
BKHA income_statement (quarterly, 2025-02-28) — Total Operating Income As Reported: -108769.00
BKHA balance_sheet (quarterly, 2025-02-28) — Tradeand Other Payables Non Current: 2415000.00
BKHA balance_sheet (quarterly, 2025-02-28) — Working Capital: 135561.00
BKHA income_statement (quarterly, 2025-05-31) — +Operating Expense: 247598.00
BKHA income_statement (quarterly, 2025-05-31) — +Total Revenue: 0.00
BKHA balance_sheet (quarterly, 2025-05-31) — Additional Paid In Capital: 0.00
BKHA income_statement (quarterly, 2025-05-31) — Basic Average Shares: 4059000.00
BKHA income_statement (quarterly, 2025-05-31) — Basic EPS: 0.06
BKHA cash_flow (quarterly, 2025-05-31) — Beginning Cash Position: 101528.00
BKHA balance_sheet (quarterly, 2025-05-31) — Capital Stock: 73363001.00
BKHA balance_sheet (quarterly, 2025-05-31) — Cash And Cash Equivalents: 72914.00
BKHA balance_sheet (quarterly, 2025-05-31) — Cash Cash Equivalents And Short Term Investments: 72914.00
BKHA balance_sheet (quarterly, 2025-05-31) — Cash Financial: 72914.00
BKHA cash_flow (quarterly, 2025-05-31) — Cash Flow From Continuing Financing Activities: 250000.00
BKHA cash_flow (quarterly, 2025-05-31) — Cash Flow From Continuing Investing Activities: 0.00
BKHA cash_flow (quarterly, 2025-05-31) — Cash Flow From Continuing Operating Activities: -278614.00
BKHA cash_flow (quarterly, 2025-05-31) — Change In Accrued Expense: -68658.00
BKHA cash_flow (quarterly, 2025-05-31) — Change In Payables And Accrued Expense: -68658.00
BKHA cash_flow (quarterly, 2025-05-31) — Change In Prepaid Assets: 37125.00
BKHA cash_flow (quarterly, 2025-05-31) — Change In Working Capital: -31533.00
BKHA cash_flow (quarterly, 2025-05-31) — Changes In Cash: -28614.00
BKHA balance_sheet (quarterly, 2025-05-31) — Common Stock: 73363001.00
BKHA balance_sheet (quarterly, 2025-05-31) — Common Stock Equity: 70836278.00
BKHA balance_sheet (quarterly, 2025-05-31) — Current Accrued Expenses: 1043.00
BKHA balance_sheet (quarterly, 2025-05-31) — Current Assets: 139523.00
BKHA balance_sheet (quarterly, 2025-05-31) — Current Liabilities: 251043.00
BKHA income_statement (quarterly, 2025-05-31) — Diluted Average Shares: 13800000.00
BKHA income_statement (quarterly, 2025-05-31) — Diluted EPS: 0.06
BKHA income_statement (quarterly, 2025-05-31) — Diluted NI Availto Com Stockholders: 520542.00
BKHA balance_sheet (quarterly, 2025-05-31) — Dueto Related Parties Current: 250000.00
BKHA income_statement (quarterly, 2025-05-31) — EBIT: 520542.00
BKHA income_statement (quarterly, 2025-05-31) — EBITDA: 520542.00
BKHA cash_flow (quarterly, 2025-05-31) — End Cash Position: 72914.00
BKHA cash_flow (quarterly, 2025-05-31) — Financing Cash Flow: 250000.00
BKHA cash_flow (quarterly, 2025-05-31) — Free Cash Flow: -278614.00
BKHA income_statement (quarterly, 2025-05-31) — General And Administrative Expense: 247598.00
BKHA income_statement (quarterly, 2025-05-31) — Interest Expense: 0.00
BKHA income_statement (quarterly, 2025-05-31) — Interest Expense Non Operating: 0.00
BKHA income_statement (quarterly, 2025-05-31) — Interest Income: 768140.00
BKHA income_statement (quarterly, 2025-05-31) — Interest Income Non Operating: 768140.00
BKHA balance_sheet (quarterly, 2025-05-31) — Invested Capital: 70836278.00
BKHA cash_flow (quarterly, 2025-05-31) — Investing Cash Flow: 0.00
BKHA cash_flow (quarterly, 2025-05-31) — Issuance Of Debt: 0.00
BKHA income_statement (quarterly, 2025-05-31) — Net Income: 520542.00
BKHA income_statement (quarterly, 2025-05-31) — Net Income Common Stockholders: 520542.00
BKHA income_statement (quarterly, 2025-05-31) — Net Income Continuous Operations: 520542.00
BKHA income_statement (quarterly, 2025-05-31) — Net Income From Continuing And Discontinued Operation: 520542.00
BKHA income_statement (quarterly, 2025-05-31) — Net Income From Continuing Operation Net Minority Interest: 520542.00
BKHA cash_flow (quarterly, 2025-05-31) — Net Income From Continuing Operations: 520542.00
BKHA income_statement (quarterly, 2025-05-31) — Net Income Including Noncontrolling Interests: 520542.00
BKHA income_statement (quarterly, 2025-05-31) — Net Interest Income: 768140.00
BKHA cash_flow (quarterly, 2025-05-31) — Net Issuance Payments Of Debt: 0.00
BKHA income_statement (quarterly, 2025-05-31) — Net Non Operating Interest Income Expense: 768140.00
BKHA cash_flow (quarterly, 2025-05-31) — Net Short Term Debt Issuance: 0.00
BKHA balance_sheet (quarterly, 2025-05-31) — Net Tangible Assets: 70836278.00
BKHA income_statement (quarterly, 2025-05-31) — Normalized EBITDA: 520542.00
BKHA income_statement (quarterly, 2025-05-31) — Normalized Income: 520542.00
BKHA cash_flow (quarterly, 2025-05-31) — Operating Cash Flow: -278614.00
BKHA income_statement (quarterly, 2025-05-31) — Operating Income: -247598.00
BKHA income_statement (quarterly, 2025-05-31) — Operating Revenue: 0.00
BKHA balance_sheet (quarterly, 2025-05-31) — Ordinary Shares Number: 8929500.00
BKHA income_statement (quarterly, 2025-05-31) — Other Gand A: 247598.00
BKHA cash_flow (quarterly, 2025-05-31) — Other Non Cash Items: -767623.00
BKHA balance_sheet (quarterly, 2025-05-31) — Other Non Current Assets: 73362798.00
BKHA balance_sheet (quarterly, 2025-05-31) — Other Payable: 250000.00
BKHA balance_sheet (quarterly, 2025-05-31) — Payables: 250000.00
BKHA balance_sheet (quarterly, 2025-05-31) — Payables And Accrued Expenses: 251043.00
BKHA balance_sheet (quarterly, 2025-05-31) — Prepaid Assets: 66609.00
BKHA income_statement (quarterly, 2025-05-31) — Pretax Income: 520542.00
BKHA balance_sheet (quarterly, 2025-05-31) — Retained Earnings: -2526723.00
BKHA income_statement (quarterly, 2025-05-31) — Selling General And Administration: 247598.00
BKHA balance_sheet (quarterly, 2025-05-31) — Share Issued: 8929500.00
BKHA cash_flow (quarterly, 2025-05-31) — Short Term Debt Issuance: 0.00
BKHA balance_sheet (quarterly, 2025-05-31) — Stockholders Equity: 70836278.00
BKHA balance_sheet (quarterly, 2025-05-31) — Tangible Book Value: 70836278.00
BKHA income_statement (quarterly, 2025-05-31) — Tax Effect Of Unusual Items: 0.00
BKHA income_statement (quarterly, 2025-05-31) — Tax Rate For Calcs: 0.21
BKHA balance_sheet (quarterly, 2025-05-31) — Total Assets: 73502321.00
BKHA balance_sheet (quarterly, 2025-05-31) — Total Capitalization: 70836278.00
BKHA balance_sheet (quarterly, 2025-05-31) — Total Equity Gross Minority Interest: 70836278.00
BKHA income_statement (quarterly, 2025-05-31) — Total Expenses: 247598.00
BKHA balance_sheet (quarterly, 2025-05-31) — Total Liabilities Net Minority Interest: 2666043.00
BKHA balance_sheet (quarterly, 2025-05-31) — Total Non Current Assets: 73362798.00
BKHA balance_sheet (quarterly, 2025-05-31) — Total Non Current Liabilities Net Minority Interest: 2415000.00
BKHA income_statement (quarterly, 2025-05-31) — Total Operating Income As Reported: -247598.00
BKHA balance_sheet (quarterly, 2025-05-31) — Tradeand Other Payables Non Current: 2415000.00
BKHA balance_sheet (quarterly, 2025-05-31) — Working Capital: -111520.00
BKHA income_statement (quarterly, 2025-08-31) — Basic Average Shares: 2029500.00
BKHA balance_sheet (quarterly, 2025-08-31) — Dueto Related Parties Current: 400000.00
BKHA cash_flow (quarterly, 2025-08-31) — Issuance Of Debt: 350000.00
BKHA cash_flow (quarterly, 2025-08-31) — Short Term Debt Issuance: 350000.00
BKHA income_statement (annual, 2025-11-30) — +Operating Expense: 915510.00
BKHA income_statement (quarterly, 2025-11-30) — +Operating Expense: 217878.00
BKHA income_statement (annual, 2025-11-30) — +Total Revenue: 0.00
BKHA income_statement (quarterly, 2025-11-30) — +Total Revenue: 0.00
BKHA balance_sheet (annual, 2025-11-30) — Additional Paid In Capital: 4538.00
BKHA balance_sheet (quarterly, 2025-11-30) — Additional Paid In Capital: 4538.00
BKHA income_statement (annual, 2025-11-30) — Basic Average Shares: 7032216.00
BKHA income_statement (annual, 2025-11-30) — Basic EPS: 0.19
BKHA cash_flow (annual, 2025-11-30) — Beginning Cash Position: 264842.00
BKHA cash_flow (quarterly, 2025-11-30) — Beginning Cash Position: 15000.00
BKHA balance_sheet (annual, 2025-11-30) — Capital Stock: 23827352.00
BKHA balance_sheet (quarterly, 2025-11-30) — Capital Stock: 23827352.00
BKHA balance_sheet (annual, 2025-11-30) — Cash And Cash Equivalents: 39521.00
BKHA balance_sheet (quarterly, 2025-11-30) — Cash And Cash Equivalents: 39521.00
BKHA balance_sheet (annual, 2025-11-30) — Cash Cash Equivalents And Short Term Investments: 39521.00
BKHA balance_sheet (quarterly, 2025-11-30) — Cash Cash Equivalents And Short Term Investments: 39521.00
BKHA balance_sheet (annual, 2025-11-30) — Cash Financial: 39521.00
BKHA balance_sheet (quarterly, 2025-11-30) — Cash Financial: 39521.00
BKHA cash_flow (annual, 2025-11-30) — Cash Flow From Continuing Financing Activities: -49835745.00
BKHA cash_flow (quarterly, 2025-11-30) — Cash Flow From Continuing Financing Activities: 425000.00
BKHA cash_flow (annual, 2025-11-30) — Cash Flow From Continuing Investing Activities: 50260745.00
BKHA cash_flow (quarterly, 2025-11-30) — Cash Flow From Continuing Investing Activities: -300000.00
BKHA cash_flow (annual, 2025-11-30) — Cash Flow From Continuing Operating Activities: -650321.00
BKHA cash_flow (quarterly, 2025-11-30) — Cash Flow From Continuing Operating Activities: -100479.00
BKHA cash_flow (annual, 2025-11-30) — Change In Accrued Expense: 240885.00
BKHA cash_flow (quarterly, 2025-11-30) — Change In Accrued Expense: 114591.00
BKHA cash_flow (annual, 2025-11-30) — Change In Payables And Accrued Expense: 240885.00
BKHA cash_flow (quarterly, 2025-11-30) — Change In Payables And Accrued Expense: 114591.00
BKHA cash_flow (annual, 2025-11-30) — Change In Prepaid Assets: 37960.00
BKHA cash_flow (quarterly, 2025-11-30) — Change In Prepaid Assets: 18261.00
BKHA cash_flow (annual, 2025-11-30) — Change In Working Capital: 278845.00
BKHA cash_flow (quarterly, 2025-11-30) — Change In Working Capital: 132852.00
BKHA cash_flow (annual, 2025-11-30) — Changes In Cash: -225321.00
BKHA cash_flow (quarterly, 2025-11-30) — Changes In Cash: 24521.00
BKHA balance_sheet (annual, 2025-11-30) — Common Stock: 23827352.00
BKHA balance_sheet (quarterly, 2025-11-30) — Common Stock: 23827352.00
BKHA balance_sheet (annual, 2025-11-30) — Common Stock Equity: 19980706.00
BKHA balance_sheet (quarterly, 2025-11-30) — Common Stock Equity: 19980706.00
BKHA cash_flow (annual, 2025-11-30) — Common Stock Issuance: 0.00
BKHA cash_flow (quarterly, 2025-11-30) — Common Stock Issuance: 0.00
BKHA cash_flow (annual, 2025-11-30) — Common Stock Payments: -51010745.00
BKHA cash_flow (quarterly, 2025-11-30) — Common Stock Payments: 0.00
BKHA balance_sheet (annual, 2025-11-30) — Current Accrued Expenses: 311864.00
BKHA balance_sheet (quarterly, 2025-11-30) — Current Accrued Expenses: 311864.00
BKHA balance_sheet (annual, 2025-11-30) — Current Assets: 50790.00
BKHA balance_sheet (quarterly, 2025-11-30) — Current Assets: 50790.00
BKHA balance_sheet (annual, 2025-11-30) — Current Debt: 595369.00
BKHA balance_sheet (quarterly, 2025-11-30) — Current Debt: 595369.00
BKHA balance_sheet (annual, 2025-11-30) — Current Debt And Capital Lease Obligation: 595369.00
BKHA balance_sheet (quarterly, 2025-11-30) — Current Debt And Capital Lease Obligation: 595369.00
BKHA balance_sheet (annual, 2025-11-30) — Current Liabilities: 1482233.00
BKHA balance_sheet (quarterly, 2025-11-30) — Current Liabilities: 1482233.00
BKHA income_statement (annual, 2025-11-30) — Diluted Average Shares: 7032216.00
BKHA income_statement (annual, 2025-11-30) — Diluted EPS: 0.19
BKHA income_statement (annual, 2025-11-30) — Diluted NI Availto Com Stockholders: 1329557.00
BKHA income_statement (quarterly, 2025-11-30) — Diluted NI Availto Com Stockholders: -3765.00
BKHA balance_sheet (annual, 2025-11-30) — Dueto Related Parties Current: 575000.00
BKHA balance_sheet (quarterly, 2025-11-30) — Dueto Related Parties Current: 575000.00
BKHA income_statement (annual, 2025-11-30) — EBIT: 1345011.00
BKHA income_statement (quarterly, 2025-11-30) — EBIT: 2042643.00
BKHA income_statement (annual, 2025-11-30) — EBITDA: 1345011.00
BKHA income_statement (quarterly, 2025-11-30) — EBITDA: 2042643.00
BKHA cash_flow (annual, 2025-11-30) — End Cash Position: 39521.00
BKHA cash_flow (quarterly, 2025-11-30) — End Cash Position: 39521.00
BKHA cash_flow (annual, 2025-11-30) — Financing Cash Flow: -49835745.00
BKHA cash_flow (quarterly, 2025-11-30) — Financing Cash Flow: 425000.00
BKHA cash_flow (annual, 2025-11-30) — Free Cash Flow: -650321.00
BKHA cash_flow (quarterly, 2025-11-30) — Free Cash Flow: -100479.00
BKHA cash_flow (annual, 2025-11-30) — Gain Loss On Investment Securities: -92.00
BKHA cash_flow (quarterly, 2025-11-30) — Gain Loss On Investment Securities: 1012.00
BKHA income_statement (annual, 2025-11-30) — Gain On Sale Of Security: 92.00
BKHA income_statement (quarterly, 2025-11-30) — Gain On Sale Of Security: -1012.00
BKHA income_statement (annual, 2025-11-30) — General And Administrative Expense: 915510.00
BKHA income_statement (quarterly, 2025-11-30) — General And Administrative Expense: 217878.00
BKHA income_statement (annual, 2025-11-30) — Interest Expense: 15454.00
BKHA income_statement (annual, 2025-11-30) — Interest Expense Non Operating: 15454.00
BKHA income_statement (annual, 2025-11-30) — Interest Income: 2260429.00
BKHA income_statement (quarterly, 2025-11-30) — Interest Income: 230579.00
BKHA income_statement (annual, 2025-11-30) — Interest Income Non Operating: 2260429.00
BKHA income_statement (quarterly, 2025-11-30) — Interest Income Non Operating: 230579.00
BKHA balance_sheet (annual, 2025-11-30) — Interest Payable: 15454.00
BKHA balance_sheet (quarterly, 2025-11-30) — Interest Payable: 15454.00
BKHA balance_sheet (annual, 2025-11-30) — Invested Capital: 20576075.00
BKHA balance_sheet (quarterly, 2025-11-30) — Invested Capital: 20576075.00
BKHA cash_flow (annual, 2025-11-30) — Investing Cash Flow: 50260745.00
BKHA cash_flow (quarterly, 2025-11-30) — Investing Cash Flow: -300000.00
BKHA cash_flow (annual, 2025-11-30) — Issuance Of Capital Stock: 0.00
BKHA cash_flow (quarterly, 2025-11-30) — Issuance Of Capital Stock: 0.00
BKHA cash_flow (annual, 2025-11-30) — Issuance Of Debt: 600000.00
BKHA cash_flow (quarterly, 2025-11-30) — Issuance Of Debt: 250000.00
BKHA cash_flow (annual, 2025-11-30) — Net Common Stock Issuance: -51010745.00
BKHA cash_flow (quarterly, 2025-11-30) — Net Common Stock Issuance: 0.00
BKHA balance_sheet (annual, 2025-11-30) — Net Debt: 555848.00
BKHA balance_sheet (quarterly, 2025-11-30) — Net Debt: 555848.00
BKHA income_statement (annual, 2025-11-30) — Net Income: 1329557.00
BKHA income_statement (quarterly, 2025-11-30) — Net Income: -3765.00
BKHA income_statement (annual, 2025-11-30) — Net Income Common Stockholders: 1329557.00
BKHA income_statement (quarterly, 2025-11-30) — Net Income Common Stockholders: -3765.00
BKHA income_statement (annual, 2025-11-30) — Net Income Continuous Operations: 1329557.00
BKHA income_statement (quarterly, 2025-11-30) — Net Income Continuous Operations: -3765.00
BKHA income_statement (annual, 2025-11-30) — Net Income From Continuing And Discontinued Operation: 1329557.00
BKHA income_statement (quarterly, 2025-11-30) — Net Income From Continuing And Discontinued Operation: -3765.00
BKHA income_statement (annual, 2025-11-30) — Net Income From Continuing Operation Net Minority Interest: 1329557.00
BKHA income_statement (quarterly, 2025-11-30) — Net Income From Continuing Operation Net Minority Interest: -3765.00
BKHA cash_flow (annual, 2025-11-30) — Net Income From Continuing Operations: 1329557.00
BKHA cash_flow (quarterly, 2025-11-30) — Net Income From Continuing Operations: -3765.00
BKHA income_statement (annual, 2025-11-30) — Net Income Including Noncontrolling Interests: 1329557.00
BKHA income_statement (quarterly, 2025-11-30) — Net Income Including Noncontrolling Interests: -3765.00
BKHA income_statement (annual, 2025-11-30) — Net Interest Income: 2244975.00
BKHA income_statement (quarterly, 2025-11-30) — Net Interest Income: 215125.00
BKHA cash_flow (annual, 2025-11-30) — Net Investment Purchase And Sale: 0.00
BKHA cash_flow (quarterly, 2025-11-30) — Net Investment Purchase And Sale: 0.00
BKHA cash_flow (annual, 2025-11-30) — Net Issuance Payments Of Debt: 600000.00
BKHA cash_flow (quarterly, 2025-11-30) — Net Issuance Payments Of Debt: 250000.00
BKHA income_statement (annual, 2025-11-30) — Net Non Operating Interest Income Expense: 2244975.00
BKHA income_statement (quarterly, 2025-11-30) — Net Non Operating Interest Income Expense: 215125.00
BKHA cash_flow (annual, 2025-11-30) — Net Other Financing Charges: 575000.00
BKHA cash_flow (quarterly, 2025-11-30) — Net Other Financing Charges: 175000.00
BKHA cash_flow (annual, 2025-11-30) — Net Other Investing Changes: 50260745.00
BKHA cash_flow (quarterly, 2025-11-30) — Net Other Investing Changes: -300000.00
BKHA cash_flow (annual, 2025-11-30) — Net Short Term Debt Issuance: 600000.00
BKHA cash_flow (quarterly, 2025-11-30) — Net Short Term Debt Issuance: 250000.00
BKHA balance_sheet (annual, 2025-11-30) — Net Tangible Assets: 19980706.00
BKHA balance_sheet (quarterly, 2025-11-30) — Net Tangible Assets: 19980706.00
BKHA income_statement (annual, 2025-11-30) — Normalized EBITDA: 1344919.00
BKHA income_statement (quarterly, 2025-11-30) — Normalized EBITDA: 2043655.00
BKHA income_statement (annual, 2025-11-30) — Normalized Income: 1329484.32
BKHA income_statement (quarterly, 2025-11-30) — Normalized Income: -2753.00
BKHA cash_flow (annual, 2025-11-30) — Operating Cash Flow: -650321.00
BKHA cash_flow (quarterly, 2025-11-30) — Operating Cash Flow: -100479.00
BKHA cash_flow (annual, 2025-11-30) — Operating Gains Losses: -92.00
BKHA cash_flow (quarterly, 2025-11-30) — Operating Gains Losses: 1012.00
BKHA income_statement (annual, 2025-11-30) — Operating Income: -915510.00
BKHA income_statement (quarterly, 2025-11-30) — Operating Income: -217878.00
BKHA income_statement (annual, 2025-11-30) — Operating Revenue: 0.00
BKHA income_statement (quarterly, 2025-11-30) — Operating Revenue: 0.00
BKHA balance_sheet (annual, 2025-11-30) — Ordinary Shares Number: 4153577.00
BKHA balance_sheet (quarterly, 2025-11-30) — Ordinary Shares Number: 4153577.00
BKHA balance_sheet (annual, 2025-11-30) — Other Current Borrowings: 595369.00
BKHA balance_sheet (quarterly, 2025-11-30) — Other Current Borrowings: 595369.00
BKHA income_statement (annual, 2025-11-30) — Other Gand A: 915510.00
BKHA income_statement (quarterly, 2025-11-30) — Other Gand A: 217878.00
BKHA income_statement (annual, 2025-11-30) — Other Income Expense: 92.00
BKHA income_statement (quarterly, 2025-11-30) — Other Income Expense: -1012.00
BKHA cash_flow (annual, 2025-11-30) — Other Non Cash Items: -2258631.00
BKHA cash_flow (quarterly, 2025-11-30) — Other Non Cash Items: -230578.00
BKHA balance_sheet (annual, 2025-11-30) — Other Non Current Assets: 23827149.00
BKHA balance_sheet (quarterly, 2025-11-30) — Other Non Current Assets: 23827149.00
BKHA balance_sheet (annual, 2025-11-30) — Payables: 575000.00
BKHA balance_sheet (quarterly, 2025-11-30) — Payables: 575000.00
BKHA balance_sheet (annual, 2025-11-30) — Payables And Accrued Expenses: 886864.00
BKHA balance_sheet (quarterly, 2025-11-30) — Payables And Accrued Expenses: 886864.00
BKHA balance_sheet (annual, 2025-11-30) — Prepaid Assets: 11269.00
BKHA balance_sheet (quarterly, 2025-11-30) — Prepaid Assets: 11269.00
BKHA income_statement (annual, 2025-11-30) — Pretax Income: 1329557.00
BKHA income_statement (quarterly, 2025-11-30) — Pretax Income: -3765.00
BKHA cash_flow (annual, 2025-11-30) — Purchase Of Investment: 0.00
BKHA cash_flow (quarterly, 2025-11-30) — Purchase Of Investment: 0.00
BKHA cash_flow (annual, 2025-11-30) — Repayment Of Debt: 0.00
BKHA cash_flow (quarterly, 2025-11-30) — Repayment Of Debt: 0.00
BKHA cash_flow (annual, 2025-11-30) — Repurchase Of Capital Stock: -51010745.00
BKHA cash_flow (quarterly, 2025-11-30) — Repurchase Of Capital Stock: 0.00
BKHA balance_sheet (annual, 2025-11-30) — Retained Earnings: -3851184.00
BKHA balance_sheet (quarterly, 2025-11-30) — Retained Earnings: -3851184.00
BKHA income_statement (annual, 2025-11-30) — Selling General And Administration: 915510.00
BKHA income_statement (quarterly, 2025-11-30) — Selling General And Administration: 217878.00
BKHA balance_sheet (annual, 2025-11-30) — Share Issued: 4153577.00
BKHA balance_sheet (quarterly, 2025-11-30) — Share Issued: 4153577.00
BKHA cash_flow (annual, 2025-11-30) — Short Term Debt Issuance: 600000.00
BKHA cash_flow (quarterly, 2025-11-30) — Short Term Debt Issuance: 250000.00
BKHA cash_flow (annual, 2025-11-30) — Short Term Debt Payments: 0.00
BKHA cash_flow (quarterly, 2025-11-30) — Short Term Debt Payments: 0.00
BKHA balance_sheet (annual, 2025-11-30) — Stockholders Equity: 19980706.00
BKHA balance_sheet (quarterly, 2025-11-30) — Stockholders Equity: 19980706.00
BKHA balance_sheet (annual, 2025-11-30) — Tangible Book Value: 19980706.00
BKHA balance_sheet (quarterly, 2025-11-30) — Tangible Book Value: 19980706.00
BKHA income_statement (annual, 2025-11-30) — Tax Effect Of Unusual Items: 19.32
BKHA income_statement (quarterly, 2025-11-30) — Tax Effect Of Unusual Items: 0.00
BKHA income_statement (annual, 2025-11-30) — Tax Rate For Calcs: 0.21
BKHA income_statement (quarterly, 2025-11-30) — Tax Rate For Calcs: 0.00
BKHA balance_sheet (annual, 2025-11-30) — Total Assets: 23877939.00
BKHA balance_sheet (quarterly, 2025-11-30) — Total Assets: 23877939.00
BKHA balance_sheet (annual, 2025-11-30) — Total Capitalization: 19980706.00
BKHA balance_sheet (quarterly, 2025-11-30) — Total Capitalization: 19980706.00
BKHA balance_sheet (annual, 2025-11-30) — Total Debt: 595369.00
BKHA balance_sheet (quarterly, 2025-11-30) — Total Debt: 595369.00
BKHA balance_sheet (annual, 2025-11-30) — Total Equity Gross Minority Interest: 19980706.00
BKHA balance_sheet (quarterly, 2025-11-30) — Total Equity Gross Minority Interest: 19980706.00
BKHA income_statement (annual, 2025-11-30) — Total Expenses: 915510.00
BKHA income_statement (quarterly, 2025-11-30) — Total Expenses: 217878.00
BKHA balance_sheet (annual, 2025-11-30) — Total Liabilities Net Minority Interest: 3897233.00
BKHA balance_sheet (quarterly, 2025-11-30) — Total Liabilities Net Minority Interest: 3897233.00
BKHA balance_sheet (annual, 2025-11-30) — Total Non Current Assets: 23827149.00
BKHA balance_sheet (quarterly, 2025-11-30) — Total Non Current Assets: 23827149.00
BKHA balance_sheet (annual, 2025-11-30) — Total Non Current Liabilities Net Minority Interest: 2415000.00
BKHA balance_sheet (quarterly, 2025-11-30) — Total Non Current Liabilities Net Minority Interest: 2415000.00
BKHA income_statement (annual, 2025-11-30) — Total Operating Income As Reported: -915510.00
BKHA income_statement (quarterly, 2025-11-30) — Total Operating Income As Reported: -217878.00
BKHA income_statement (annual, 2025-11-30) — Total Unusual Items: 92.00
BKHA income_statement (quarterly, 2025-11-30) — Total Unusual Items: -1012.00
BKHA income_statement (annual, 2025-11-30) — Total Unusual Items Excluding Goodwill: 92.00
BKHA income_statement (quarterly, 2025-11-30) — Total Unusual Items Excluding Goodwill: -1012.00
BKHA balance_sheet (annual, 2025-11-30) — Tradeand Other Payables Non Current: 2415000.00
BKHA balance_sheet (quarterly, 2025-11-30) — Tradeand Other Payables Non Current: 2415000.00
BKHA balance_sheet (annual, 2025-11-30) — Working Capital: -1431443.00
BKHA balance_sheet (quarterly, 2025-11-30) — Working Capital: -1431443.00
BKHA income_statement (quarterly, 2026-02-28) — +Operating Expense: 54189.00
BKHA income_statement (quarterly, 2026-02-28) — +Total Revenue: 0.00
BKHA balance_sheet (quarterly, 2026-02-28) — Accounts Payable: 232772.00
BKHA balance_sheet (quarterly, 2026-02-28) — Additional Paid In Capital: 4538.00
BKHA income_statement (quarterly, 2026-02-28) — Basic Average Shares: 4153577.00
BKHA income_statement (quarterly, 2026-02-28) — Basic EPS: 0.03
BKHA cash_flow (quarterly, 2026-02-28) — Beginning Cash Position: 39521.00
BKHA balance_sheet (quarterly, 2026-02-28) — Capital Stock: 24640794.00
BKHA balance_sheet (quarterly, 2026-02-28) — Cash And Cash Equivalents: 178407.00
BKHA balance_sheet (quarterly, 2026-02-28) — Cash Cash Equivalents And Short Term Investments: 178407.00
BKHA balance_sheet (quarterly, 2026-02-28) — Cash Financial: 178407.00
BKHA cash_flow (quarterly, 2026-02-28) — Cash Flow From Continuing Financing Activities: 848388.00
BKHA cash_flow (quarterly, 2026-02-28) — Cash Flow From Continuing Investing Activities: -600000.00
BKHA cash_flow (quarterly, 2026-02-28) — Cash Flow From Continuing Operating Activities: -109502.00
BKHA cash_flow (quarterly, 2026-02-28) — Change In Accrued Expense: -44189.00
BKHA cash_flow (quarterly, 2026-02-28) — Change In Payables And Accrued Expense: -44189.00
BKHA cash_flow (quarterly, 2026-02-28) — Change In Prepaid Assets: 8324.00
BKHA cash_flow (quarterly, 2026-02-28) — Change In Working Capital: -35865.00
BKHA cash_flow (quarterly, 2026-02-28) — Changes In Cash: 138886.00
BKHA balance_sheet (quarterly, 2026-02-28) — Common Stock: 24640794.00
BKHA balance_sheet (quarterly, 2026-02-28) — Common Stock Equity: 20120511.00
BKHA balance_sheet (quarterly, 2026-02-28) — Current Accrued Expenses: 32906.00
BKHA balance_sheet (quarterly, 2026-02-28) — Current Assets: 181352.00
BKHA balance_sheet (quarterly, 2026-02-28) — Current Debt: 997366.00
BKHA balance_sheet (quarterly, 2026-02-28) — Current Debt And Capital Lease Obligation: 997366.00
BKHA balance_sheet (quarterly, 2026-02-28) — Current Liabilities: 2286432.00
BKHA income_statement (quarterly, 2026-02-28) — Diluted Average Shares: 4153577.00
BKHA income_statement (quarterly, 2026-02-28) — Diluted EPS: 0.03
BKHA income_statement (quarterly, 2026-02-28) — Diluted NI Availto Com Stockholders: 139805.00
BKHA balance_sheet (quarterly, 2026-02-28) — Dueto Related Parties Current: 1023388.00
BKHA income_statement (quarterly, 2026-02-28) — EBIT: 159253.00
BKHA income_statement (quarterly, 2026-02-28) — EBITDA: 159253.00
BKHA cash_flow (quarterly, 2026-02-28) — End Cash Position: 178407.00
BKHA cash_flow (quarterly, 2026-02-28) — Financing Cash Flow: 848388.00
BKHA cash_flow (quarterly, 2026-02-28) — Free Cash Flow: -109502.00
BKHA income_statement (quarterly, 2026-02-28) — General And Administrative Expense: 54189.00
BKHA income_statement (quarterly, 2026-02-28) — Interest Expense: 19449.00
BKHA income_statement (quarterly, 2026-02-28) — Interest Expense Non Operating: 19449.00
BKHA income_statement (quarterly, 2026-02-28) — Interest Income: 213442.00
BKHA income_statement (quarterly, 2026-02-28) — Interest Income Non Operating: 213442.00
BKHA balance_sheet (quarterly, 2026-02-28) — Interest Payable: 32906.00
BKHA balance_sheet (quarterly, 2026-02-28) — Invested Capital: 21117877.00
BKHA cash_flow (quarterly, 2026-02-28) — Investing Cash Flow: -600000.00
BKHA cash_flow (quarterly, 2026-02-28) — Issuance Of Debt: 400000.00
BKHA balance_sheet (quarterly, 2026-02-28) — Net Debt: 818959.00
BKHA income_statement (quarterly, 2026-02-28) — Net Income: 139805.00
BKHA income_statement (quarterly, 2026-02-28) — Net Income Common Stockholders: 139805.00
BKHA income_statement (quarterly, 2026-02-28) — Net Income Continuous Operations: 139804.00
BKHA income_statement (quarterly, 2026-02-28) — Net Income From Continuing And Discontinued Operation: 139805.00
BKHA income_statement (quarterly, 2026-02-28) — Net Income From Continuing Operation Net Minority Interest: 139805.00
BKHA cash_flow (quarterly, 2026-02-28) — Net Income From Continuing Operations: 139805.00
BKHA income_statement (quarterly, 2026-02-28) — Net Income Including Noncontrolling Interests: 139804.00
BKHA income_statement (quarterly, 2026-02-28) — Net Interest Income: 193993.00
BKHA cash_flow (quarterly, 2026-02-28) — Net Issuance Payments Of Debt: 400000.00
BKHA income_statement (quarterly, 2026-02-28) — Net Non Operating Interest Income Expense: 193993.00
BKHA cash_flow (quarterly, 2026-02-28) — Net Other Financing Charges: 448388.00
BKHA cash_flow (quarterly, 2026-02-28) — Net Other Investing Changes: -600000.00
BKHA cash_flow (quarterly, 2026-02-28) — Net Short Term Debt Issuance: 400000.00
BKHA balance_sheet (quarterly, 2026-02-28) — Net Tangible Assets: 20120511.00
BKHA income_statement (quarterly, 2026-02-28) — Normalized EBITDA: 159253.00
BKHA income_statement (quarterly, 2026-02-28) — Normalized Income: 139805.00
BKHA cash_flow (quarterly, 2026-02-28) — Operating Cash Flow: -109502.00
BKHA income_statement (quarterly, 2026-02-28) — Operating Income: -54189.00
BKHA income_statement (quarterly, 2026-02-28) — Operating Revenue: 0.00
BKHA balance_sheet (quarterly, 2026-02-28) — Ordinary Shares Number: 4153577.00
BKHA balance_sheet (quarterly, 2026-02-28) — Other Current Borrowings: 997366.00
BKHA income_statement (quarterly, 2026-02-28) — Other Gand A: 54189.00
BKHA cash_flow (quarterly, 2026-02-28) — Other Non Cash Items: -213442.00
BKHA balance_sheet (quarterly, 2026-02-28) — Other Non Current Assets: 24640591.00
BKHA balance_sheet (quarterly, 2026-02-28) — Payables: 1256160.00
BKHA balance_sheet (quarterly, 2026-02-28) — Payables And Accrued Expenses: 1289066.00
BKHA balance_sheet (quarterly, 2026-02-28) — Prepaid Assets: 2945.00
BKHA income_statement (quarterly, 2026-02-28) — Pretax Income: 139804.00
BKHA balance_sheet (quarterly, 2026-02-28) — Retained Earnings: -4524821.00
BKHA income_statement (quarterly, 2026-02-28) — Selling General And Administration: 54189.00
BKHA balance_sheet (quarterly, 2026-02-28) — Share Issued: 4153577.00
BKHA cash_flow (quarterly, 2026-02-28) — Short Term Debt Issuance: 400000.00
BKHA balance_sheet (quarterly, 2026-02-28) — Stockholders Equity: 20120511.00
BKHA balance_sheet (quarterly, 2026-02-28) — Tangible Book Value: 20120511.00
BKHA income_statement (quarterly, 2026-02-28) — Tax Effect Of Unusual Items: 0.00
BKHA income_statement (quarterly, 2026-02-28) — Tax Rate For Calcs: 0.40
BKHA balance_sheet (quarterly, 2026-02-28) — Total Assets: 24821943.00
BKHA balance_sheet (quarterly, 2026-02-28) — Total Capitalization: 20120511.00
BKHA balance_sheet (quarterly, 2026-02-28) — Total Debt: 997366.00
BKHA balance_sheet (quarterly, 2026-02-28) — Total Equity Gross Minority Interest: 20120511.00
BKHA income_statement (quarterly, 2026-02-28) — Total Expenses: 54189.00
BKHA balance_sheet (quarterly, 2026-02-28) — Total Liabilities Net Minority Interest: 4701432.00
BKHA balance_sheet (quarterly, 2026-02-28) — Total Non Current Assets: 24640591.00
BKHA balance_sheet (quarterly, 2026-02-28) — Total Non Current Liabilities Net Minority Interest: 2415000.00
BKHA income_statement (quarterly, 2026-02-28) — Total Operating Income As Reported: -54189.00
BKHA balance_sheet (quarterly, 2026-02-28) — Tradeand Other Payables Non Current: 2415000.00
BKHA balance_sheet (quarterly, 2026-02-28) — Working Capital: -2105080.00
BKHA income_statement (quarterly, 2026-05-31) — +Operating Expense: 109215.00
BKHA income_statement (quarterly, 2026-05-31) — +Total Revenue: 0.00
BKHA balance_sheet (quarterly, 2026-05-31) — Accounts Payable: 153952.00
BKHA balance_sheet (quarterly, 2026-05-31) — Additional Paid In Capital: 4538.00
BKHA income_statement (quarterly, 2026-05-31) — Basic Average Shares: 4059000.00
BKHA income_statement (quarterly, 2026-05-31) — Basic EPS: 0.02
BKHA cash_flow (quarterly, 2026-05-31) — Beginning Cash Position: 178407.00
BKHA balance_sheet (quarterly, 2026-05-31) — Capital Stock: 25313319.00
BKHA balance_sheet (quarterly, 2026-05-31) — Cash And Cash Equivalents: 11583.00
BKHA balance_sheet (quarterly, 2026-05-31) — Cash Cash Equivalents And Short Term Investments: 11583.00
BKHA balance_sheet (quarterly, 2026-05-31) — Cash Financial: 11583.00
BKHA cash_flow (quarterly, 2026-05-31) — Cash Flow From Continuing Financing Activities: 519813.00
BKHA cash_flow (quarterly, 2026-05-31) — Cash Flow From Continuing Investing Activities: -450000.00
BKHA cash_flow (quarterly, 2026-05-31) — Cash Flow From Continuing Operating Activities: -236637.00
BKHA cash_flow (quarterly, 2026-05-31) — Change In Accrued Expense: -54439.00
BKHA cash_flow (quarterly, 2026-05-31) — Change In Payables And Accrued Expense: -54439.00
BKHA cash_flow (quarterly, 2026-05-31) — Change In Prepaid Assets: -48602.00
BKHA cash_flow (quarterly, 2026-05-31) — Change In Working Capital: -103041.00
BKHA cash_flow (quarterly, 2026-05-31) — Changes In Cash: -166824.00
BKHA balance_sheet (quarterly, 2026-05-31) — Common Stock: 25313319.00
BKHA balance_sheet (quarterly, 2026-05-31) — Common Stock Equity: 20209440.00
BKHA balance_sheet (quarterly, 2026-05-31) — Current Accrued Expenses: 57287.00
BKHA balance_sheet (quarterly, 2026-05-31) — Current Assets: 63130.00
BKHA balance_sheet (quarterly, 2026-05-31) — Current Debt: 1232366.00
BKHA balance_sheet (quarterly, 2026-05-31) — Current Debt And Capital Lease Obligation: 1232366.00
BKHA balance_sheet (quarterly, 2026-05-31) — Current Liabilities: 2751806.00
BKHA income_statement (quarterly, 2026-05-31) — Diluted Average Shares: 4248154.00
BKHA income_statement (quarterly, 2026-05-31) — Diluted EPS: 0.02
BKHA income_statement (quarterly, 2026-05-31) — Diluted NI Availto Com Stockholders: 88929.00
BKHA balance_sheet (quarterly, 2026-05-31) — Dueto Related Parties Current: 1308201.00
BKHA income_statement (quarterly, 2026-05-31) — EBIT: 113310.00
BKHA income_statement (quarterly, 2026-05-31) — EBITDA: 113310.00
BKHA cash_flow (quarterly, 2026-05-31) — End Cash Position: 11583.00
BKHA cash_flow (quarterly, 2026-05-31) — Financing Cash Flow: 519813.00
BKHA cash_flow (quarterly, 2026-05-31) — Free Cash Flow: -236637.00
BKHA income_statement (quarterly, 2026-05-31) — General And Administrative Expense: 109215.00
BKHA income_statement (quarterly, 2026-05-31) — Interest Expense: 24381.00
BKHA income_statement (quarterly, 2026-05-31) — Interest Expense Non Operating: 24381.00
BKHA income_statement (quarterly, 2026-05-31) — Interest Income: 222525.00
BKHA income_statement (quarterly, 2026-05-31) — Interest Income Non Operating: 222525.00
BKHA balance_sheet (quarterly, 2026-05-31) — Interest Payable: 57287.00
BKHA balance_sheet (quarterly, 2026-05-31) — Invested Capital: 21441806.00
BKHA cash_flow (quarterly, 2026-05-31) — Investing Cash Flow: -450000.00
BKHA cash_flow (quarterly, 2026-05-31) — Issuance Of Debt: 235000.00
BKHA balance_sheet (quarterly, 2026-05-31) — Net Debt: 1220783.00
BKHA income_statement (quarterly, 2026-05-31) — Net Income: 88929.00
BKHA income_statement (quarterly, 2026-05-31) — Net Income Common Stockholders: 88929.00
BKHA income_statement (quarterly, 2026-05-31) — Net Income Continuous Operations: 88929.00
BKHA income_statement (quarterly, 2026-05-31) — Net Income From Continuing And Discontinued Operation: 88929.00
BKHA income_statement (quarterly, 2026-05-31) — Net Income From Continuing Operation Net Minority Interest: 88929.00
BKHA cash_flow (quarterly, 2026-05-31) — Net Income From Continuing Operations: 88929.00
BKHA income_statement (quarterly, 2026-05-31) — Net Income Including Noncontrolling Interests: 88929.00
BKHA income_statement (quarterly, 2026-05-31) — Net Interest Income: 198144.00
BKHA cash_flow (quarterly, 2026-05-31) — Net Issuance Payments Of Debt: 235000.00
BKHA income_statement (quarterly, 2026-05-31) — Net Non Operating Interest Income Expense: 198144.00
BKHA cash_flow (quarterly, 2026-05-31) — Net Other Financing Charges: 284813.00
BKHA cash_flow (quarterly, 2026-05-31) — Net Other Investing Changes: -450000.00
BKHA cash_flow (quarterly, 2026-05-31) — Net Short Term Debt Issuance: 235000.00
BKHA balance_sheet (quarterly, 2026-05-31) — Net Tangible Assets: 20209440.00
BKHA income_statement (quarterly, 2026-05-31) — Normalized EBITDA: 113310.00
BKHA income_statement (quarterly, 2026-05-31) — Normalized Income: 88929.00
BKHA cash_flow (quarterly, 2026-05-31) — Operating Cash Flow: -236637.00
BKHA income_statement (quarterly, 2026-05-31) — Operating Income: -109215.00
BKHA income_statement (quarterly, 2026-05-31) — Operating Revenue: 0.00
BKHA balance_sheet (quarterly, 2026-05-31) — Ordinary Shares Number: 4153577.00
BKHA balance_sheet (quarterly, 2026-05-31) — Other Current Borrowings: 1232366.00
BKHA income_statement (quarterly, 2026-05-31) — Other Gand A: 109215.00
BKHA cash_flow (quarterly, 2026-05-31) — Other Non Cash Items: -222525.00
BKHA balance_sheet (quarterly, 2026-05-31) — Other Non Current Assets: 25313116.00
BKHA balance_sheet (quarterly, 2026-05-31) — Payables: 1462153.00
BKHA balance_sheet (quarterly, 2026-05-31) — Payables And Accrued Expenses: 1519440.00
BKHA balance_sheet (quarterly, 2026-05-31) — Prepaid Assets: 51547.00
BKHA income_statement (quarterly, 2026-05-31) — Pretax Income: 88929.00
BKHA balance_sheet (quarterly, 2026-05-31) — Retained Earnings: -5108417.00
BKHA income_statement (quarterly, 2026-05-31) — Selling General And Administration: 109215.00
BKHA balance_sheet (quarterly, 2026-05-31) — Share Issued: 4153577.00
BKHA cash_flow (quarterly, 2026-05-31) — Short Term Debt Issuance: 235000.00
BKHA balance_sheet (quarterly, 2026-05-31) — Stockholders Equity: 20209440.00
BKHA balance_sheet (quarterly, 2026-05-31) — Tangible Book Value: 20209440.00
BKHA income_statement (quarterly, 2026-05-31) — Tax Effect Of Unusual Items: 0.00
BKHA income_statement (quarterly, 2026-05-31) — Tax Rate For Calcs: 0.40
BKHA balance_sheet (quarterly, 2026-05-31) — Total Assets: 25376246.00
BKHA balance_sheet (quarterly, 2026-05-31) — Total Capitalization: 20209440.00
BKHA balance_sheet (quarterly, 2026-05-31) — Total Debt: 1232366.00
BKHA balance_sheet (quarterly, 2026-05-31) — Total Equity Gross Minority Interest: 20209440.00
BKHA income_statement (quarterly, 2026-05-31) — Total Expenses: 109215.00
BKHA balance_sheet (quarterly, 2026-05-31) — Total Liabilities Net Minority Interest: 5166806.00
BKHA balance_sheet (quarterly, 2026-05-31) — Total Non Current Assets: 25313116.00
BKHA balance_sheet (quarterly, 2026-05-31) — Total Non Current Liabilities Net Minority Interest: 2415000.00
BKHA income_statement (quarterly, 2026-05-31) — Total Operating Income As Reported: -109215.00
BKHA balance_sheet (quarterly, 2026-05-31) — Tradeand Other Payables Non Current: 2415000.00
BKHA balance_sheet (quarterly, 2026-05-31) — Working Capital: -2688676.00
BKHT.DE income_statement (annual, 2021-12-31) — +Operating Expense: 30241000.00
BKHT.DE income_statement (annual, 2021-12-31) — +Total Revenue: 39042000.00
BKHT.DE balance_sheet (annual, 2021-12-31) — Accounts Payable: 11305000.00
BKHT.DE balance_sheet (annual, 2021-12-31) — Accounts Receivable: 11611000.00
BKHT.DE balance_sheet (annual, 2021-12-31) — Accumulated Depreciation: -2241000.00
BKHT.DE balance_sheet (annual, 2021-12-31) — Additional Paid In Capital: 227688000.00
BKHT.DE balance_sheet (annual, 2021-12-31) — Allowance For Doubtful Accounts Receivable: -583000.00
BKHT.DE income_statement (annual, 2021-12-31) — Amortization: 6240000.00
BKHT.DE cash_flow (annual, 2021-12-31) — Amortization Cash Flow: 9683000.00
BKHT.DE balance_sheet (annual, 2021-12-31) — Assets Held For Sale Current: 0.00
BKHT.DE income_statement (annual, 2021-12-31) — Basic Average Shares: 10433339.00
BKHT.DE income_statement (annual, 2021-12-31) — Basic EPS: -1.52
BKHT.DE cash_flow (annual, 2021-12-31) — Beginning Cash Position: 123544000.00
BKHT.DE balance_sheet (annual, 2021-12-31) — Buildings And Improvements: 1545000.00
BKHT.DE cash_flow (annual, 2021-12-31) — Capital Expenditure: -2469000.00
BKHT.DE cash_flow (annual, 2021-12-31) — Capital Expenditure Reported: -861000.00
BKHT.DE balance_sheet (annual, 2021-12-31) — Capital Lease Obligations: 130529000.00
BKHT.DE balance_sheet (annual, 2021-12-31) — Capital Stock: 10387000.00
BKHT.DE balance_sheet (annual, 2021-12-31) — Cash And Cash Equivalents: 30327000.00
BKHT.DE balance_sheet (annual, 2021-12-31) — Cash Cash Equivalents And Short Term Investments: 45607000.00
BKHT.DE balance_sheet (annual, 2021-12-31) — Cash Financial: 30327000.00
BKHT.DE cash_flow (annual, 2021-12-31) — Change In Inventory: -2329000.00
BKHT.DE cash_flow (annual, 2021-12-31) — Change In Other Current Assets: -1467000.00
BKHT.DE cash_flow (annual, 2021-12-31) — Change In Other Current Liabilities: 3792000.00
BKHT.DE cash_flow (annual, 2021-12-31) — Change In Payable: 7589000.00